Found 13 matching trials
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer PHASE3 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Location
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Learn More & Join Trial
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer PHASE2 To explore the efficacy and safety of chidamide combined with endocrine in ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Premenopausal Endocrine Responsive Chemotherapy Trial PHASE3 The PERCHE trial evaluated the worth of adding adjuvant chemotherapy for pr...
Show More Location
National Institute of Oncology
Learn More & Join Trial
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer PHASE2 This open-label research study is studying (Z)-endoxifen as a possible trea...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Arizona
Learn More & Join Trial
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy NA To explore the efficacy and safety of Chidamide combined with endocrine for...
Show More Learn More & Join Trial
Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES) PHASE3 CDK4/6 inhibitors are currently the standard treatment for female breast ca...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer PHASE2 This phase II study focuses on women with rapidly progressive hormone recep...
Show More Location
Jiangsu Provincial People's Hospital
Learn More & Join Trial
Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment NA The study is being conducted to evaluate the efficacy and safety of stereot...
Show More Status
Active Not Recruiting
Location
Shengjing Hospital of China Medical University
Learn More & Join Trial
Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure PHASE1 This is an open-label, single-center, exploratory, Phase Ib/II clinical tri...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients PHASE2 To compare safety of adjuvant OFS combined with anastrozole versus OFS comb...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial